Lupin seed is referred to as an antidiabetic product by the traditional medicine. Conglutin-gamma, a lupin seed glycoprotein, caused a significant plasma glucose reduction when orally administered upon glucose overload trials in rats. The aim of this work was to unveil conglutin-gamma hypothetical insulin-mimetic cellular mechanism of action. Insulin is the primary hormone responsible for proteosynthesis control through IRS/P70S6k/PHAS1 pathways modulation, glucose homeostasis and muscle differentiation and hypertrophy via muscle-specific MHC (myosin heavy chain) gene transcription control. Methods and Results: To verify if conglutin-gamma is able to modulate the same insulin-activated kinases, myoblastic C2C12 cells were incubated, after 72h of differentiation, with 100 nM insulin or 0.5 mg/ml conglutin-g. We used cells without stimulation as a negative control and cells stimulated with metformin as a positive control. We evaluated the effect of these treatment after 5, 10, 20, 30 and 240 minutes. We verified that stimulation with insulin or conglutin-gamma resulted in persistent activation of kinases of the protein synthetic pathway as well as increase of glucose transport and muscle-specific gene transcription regulation. Conclusion: Our results indicate that conglutin-gamma may regulate the same components of the insulin signaling, suggesting the potential therapeutic oral use of this protein in diabetes treatment and, in particular, the potential conglutin-gamma influence on muscle cells differentiation and hypertrophy
INSULIN-MIMETIC ACTION OF CONGLUTIN-GAMMA IN MOUSE MYOBLASTS / I. Terruzzi, P. Senesi, A. Montesano, C. Magni, A. Scarafoni, L. Luzi, M. Duranti. - In: ACTA PHYSIOLOGICA. - ISSN 1748-1708. - (2009). ((Intervento presentato al 60. convegno National Congress of the Italian Physiological Society.
INSULIN-MIMETIC ACTION OF CONGLUTIN-GAMMA IN MOUSE MYOBLASTS
I. Terruzzi;P. Senesi;A. Montesano;C. Magni;A. Scarafoni;L. Luzi;M. Duranti
2009
Abstract
Lupin seed is referred to as an antidiabetic product by the traditional medicine. Conglutin-gamma, a lupin seed glycoprotein, caused a significant plasma glucose reduction when orally administered upon glucose overload trials in rats. The aim of this work was to unveil conglutin-gamma hypothetical insulin-mimetic cellular mechanism of action. Insulin is the primary hormone responsible for proteosynthesis control through IRS/P70S6k/PHAS1 pathways modulation, glucose homeostasis and muscle differentiation and hypertrophy via muscle-specific MHC (myosin heavy chain) gene transcription control. Methods and Results: To verify if conglutin-gamma is able to modulate the same insulin-activated kinases, myoblastic C2C12 cells were incubated, after 72h of differentiation, with 100 nM insulin or 0.5 mg/ml conglutin-g. We used cells without stimulation as a negative control and cells stimulated with metformin as a positive control. We evaluated the effect of these treatment after 5, 10, 20, 30 and 240 minutes. We verified that stimulation with insulin or conglutin-gamma resulted in persistent activation of kinases of the protein synthetic pathway as well as increase of glucose transport and muscle-specific gene transcription regulation. Conclusion: Our results indicate that conglutin-gamma may regulate the same components of the insulin signaling, suggesting the potential therapeutic oral use of this protein in diabetes treatment and, in particular, the potential conglutin-gamma influence on muscle cells differentiation and hypertrophyPubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.